Table 3.
FIGO stage | Patients (n = 24) | EBT dose (Gy) | Fractions (n) | EBRT dose (Gy) | Combined dose range (Gy) | Mean combined dose (Gy) |
---|---|---|---|---|---|---|
IA | 1 | 20 | 4 | 50.4 | 70.4 | 70.4 |
IB | 7 | 12–21 | 3,4 | 20–50.4 | 40–66 | 58.5 |
IC | 4 | 10–18 | 2,3,4 | 45–59.4 | 61–69.4 | 64.1 |
IIA | 1 | 15 | 3 | 45 | 60 | 60.0 |
IIB | 5 | 12–21 | 3 | 45–46.8 | 57–66 | 60.7 |
IIIA | 1 | 20 | 5 | 45 | 65 | 65.0 |
IIIC | 4 | 8–18 | 2,3 | 41.4–50.4 | 57–60 | 58.7 |
Unknown (high-grade) | 1 | 12 | 2 | 44 | 56 | 56 |
Mean ± SDa | 15.3 ± 3.7 | 45.4 ± 6.4 | 60.7 ± 5.8 | |||
Recurrence IIIC | 1 | 25 | 5 | 55.4 | 80.4 | 80.4 |
Notes:
The mean dose and standard deviation calculations do not include the patient with recurrent cancer.
Abbreviations: Gy, gray; EBRT, external beam radiation therapy; EBT, electronic brachytherapy; SD, standard deviation; FIGO, Federation International Gynecology and Obstetrics.